Sandimmun Neoral® (Cyclosporine) Cyclosporine capsules and oral solution by Novartis. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Cyclosporine 25 mg, 50 mg, 100 mg capsules; 100 mg/mL oral solution |
|---|---|
| Manufacturer | Novartis |
| Country | Switzerland |
| Pack size | Capsule blister pack / oral solution bottle |
| Storage | Store as stated on the carton; do not refrigerate the oral solution |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Sandimmun Neoral® (Cyclosporine) Capsules and Oral Solution: A Sourcing Guide for Hospitals and Pharmacies
Sandimmun Neoral® is a cyclosporine product (calcineurin-inhibitor immunosuppressant) marketed by Novartis. The decision to prescribe cyclosporine, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Sandimmun Neoral® (cyclosporine) capsules and oral solution to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the Immunosuppressant category. Supply is in bulk/wholesale quantities only.
Sandimmun Neoral contains cyclosporine in a microemulsion formulation, supplied as soft gelatin capsules and as an oral solution. Strengths marketed in India are those on the Indian pack; the capsules are commonly listed in 25 mg, 50 mg and 100 mg strengths and the oral solution as 100 mg/mL.
How it works, according to the label: The US prescribing information for Neoral (DailyMed) describes cyclosporine as an immunosuppressive agent.
Ciclosporin (cyclosporine) is a calcineurin inhibitor with immunosuppressive action. The Neoral formulation is a microemulsion, and its labelling lists prevention of rejection after organ transplantation, along with certain autoimmune indications, depending on the country’s approved label.
Neoral is not interchangeable with other ciclosporin formulations on a milligram-for-milligram basis, and labelling advises that monitoring of blood levels is part of care. These are matters for the transplant or treating team. Procurement teams generally check that the exact formulation, strength and pack on the invoice match the order.
The current US prescribing information for Neoral (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Sandimmun Neoral pack insert.
Published literature includes the Canadian Multicentre Transplant Study Group trial of cyclosporine in cadaveric renal transplantation (N Engl J Med 1983) and later studies of the microemulsion formulation. Neoral and the original Sandimmun formulation are not interchangeable, as stated in the label. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack (confirm against the carton) |
|---|---|---|
| Cyclosporine 25 mg, 50 mg, 100 mg | Soft gelatin capsule | Blister pack (confirm against the carton) |
| Cyclosporine 100 mg/mL | Oral solution | Bottle with dosing syringe (confirm against the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
When a hospital purchase department or pharmacy evaluates Sandimmun Neoral, the usual first checks are the same as for any specialty medicine: the supplier’s wholesale drug licence and GST registration, a proper tax invoice for every consignment, and written confirmation that the stock comes from an authorised channel. A.K. Pharma supplies Sandimmun Neoral as a licensed distributor and shares the batch number, manufacturing and expiry dates and pack details on request, so that your receiving team can match the carton against the invoice before the stock is accepted.
On delivery, buyers commonly check that the carton is sealed and undamaged, that the batch number and expiry date on the carton match the invoice, and that the product is stored as directed on the pack. Any discrepancy should be reported to the supplier at once, before the product is issued for use.
Orders are supplied in bulk and wholesale quantities only, to hospitals, clinics, doctors and pharmacies. Availability, pack presentation and lead time can change with manufacturer supply, so please contact A.K. Pharma for current stock before you raise a purchase order. A.K. Pharma does not provide clinical guidance; questions about whether Sandimmun Neoral is suitable for a particular patient belong with the treating physician and the product’s approved prescribing information.
Transplant centres, hospitals, nephrology, hepatology and rheumatology units and pharmacies in India that need to source Sandimmun Neoral in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. The US label carries a boxed warning that it should be prescribed only by physicians experienced in immunosuppressive therapy; refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store as directed on the carton. The label states that capsules stay in the blister pack until use and the oral solution should not be refrigerated; check the carton for the exact temperature limit.
Sandimmun Neoral is marketed by Novartis. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Sandimmun Neoral through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Sandimmun Neoral available in India?
A.K. Pharma supplies Sandimmun Neoral® (cyclosporine) capsules and oral solution to hospitals and pharmacies in India. Contact us for current availability.
What does Sandimmun Neoral contain?
Sandimmun Neoral contains cyclosporine, marketed by Novartis. The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
Are Neoral and Sandimmun interchangeable?
The label states they are not interchangeable. Brand and formulation decisions rest with the treating physician.
How should Sandimmun Neoral be stored?
Follow the carton. Capsules stay in the blister until use and the oral solution should not be refrigerated.
What is Sandimmun Neoral?
It is a ciclosporin microemulsion product from Novartis, per the label.
Can it be swapped with other ciclosporin brands?
The labelling cautions against doing so without medical supervision. This is for the treating physician.
How should it be stored?
As directed on the carton.
Does A.K. Pharma advise on monitoring?
No. Monitoring rests with the treating team.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
